ACTIVE Injection Kit – KL provides Kenalog-40 and Lidocaine, pre-measured to facilitate quick and convenient preparation of a single injection. When injected via intramuscular and intra-articular routes, Kenalog-40 effectively relieves inflammation associated with diverse conditions from multiple systems, including rheumatic, dermatologic, and gastrointestinal disorders. This injection is also recommended for acute allergic conditions, uveitis, and inflammatory ocular conditions unresponsive to topical steroids.
Pharmaceutica North America guarantees delivering high-quality ingredients that are manufactured and distributed in accordance with cGMP at an FDA and DEA registered facility. Our ACTIVE Injection Kit – KL delivers what you’d expect from one of the nation’s leading compounding pharmaceutical companies—a complete package with all the components needed for an injection, including a syringe, needles, and ammonia inhalant ampule.
Approved and Potential Uses of Kenalog-40 and Lidocaine Injection:
Kenalog-40 (Triamcinolone Acetonide injectable suspension, USP), a synthetic glucocorticoid primarily used as an anti-inflammatory agent, achieves this effect by suppressing the immune system, reversing capillary permeability, and inhibiting polymorphonuclear leukocytes and fibroblasts. Kenalog-40 injection reaches peak plasma time in 8 to 10 hours, so it’s generally not recommended for acute stress conditions.
Lidocaine is an aminoethylamide anesthetic that prevents pain by blocking voltage-gated sodium channels in nerve cell membranes. Lidocaine provides pain relief in 3 to 5 minutes, which may help confirm the diagnosis for rheumatic conditions.
Therapeutic injection of Kenalog-40 and Lidocaine may be administered via intra-articular, soft tissue, and intramuscular routes. Consider using the ACTIVE Injection Kit – KL for the following conditions:
Rheumatic disorders – Injection therapy for adjunctive treatment of rheumatoid arthritis (including juvenile arthritis), osteoarthritis, ankylosing spondylitis, psoriatic arthritis, acute rheumatic carditis, gouty arthritis, acute and subacute bursitis, nonspecific tenosynovitis, epicondylitis and synovitis, systemic lupus erythematosus, dermatomyositis, and polymyositis.
Dermatologic diseases – Bullous dermatitis herpetiformis, exfoliative erythroderma, severe erythema multiforme, pemphigus, and mycosis fungoides.
Ophthalmic diseases – Uveitis, temporal arteritis, sympathetic ophthalmia, and ocular inflammatory conditions unresponsive to topical corticosteroids.
Allergic conditions – To control severe allergic conditions unresponsive to conventional treatment in asthma, atopic dermatitis, contact dermatitis, seasonal allergic rhinitis, drug hypersensitivity reactions, serum sickness, and transfusion reactions.
Endocrine disorders – To treat primary or secondary adrenocortical insufficiency, hypercalcemia associated with cancer, nonsuppurative thyroiditis, and congenital adrenal hyperplasia—use in conjunction with mineralocorticoids where applicable.
Gastrointestinal conditions – To relieve acute flare-ups of ulcerative colitis and regional enteritis.
Respiratory diseases – Used concurrently with antituberculous chemotherapy for fulminating or disseminated pulmonary tuberculosis.
Renal disease – Used to induce diuresis or remission of proteinuria due to lupus erythematosus or idiopathic nephrotic syndrome.
Hematologic disorders – For rare conditions such as acquired hemolytic anemia, pure red cell aplasia, and Diamond-Blackfan anemia.
Components Included in the ACTIVE Injection Kit – KL:
When you purchase the ACTIVE Injection Kit – KL from Pharmaceutica North America, you can count on stable products, competitive pricing and a team of experts standing ready to answer questions and help you find the pharmaceutical products you need. Contact us today to learn about our fast shipping and to experience first-class customer service in action.